![Teva Pharmaceutical has been given a green light by the European Commission (EC) for Lonquex, a rival to Amgen's blockbuster Neulasta. | New Drug Approvals Teva Pharmaceutical has been given a green light by the European Commission (EC) for Lonquex, a rival to Amgen's blockbuster Neulasta. | New Drug Approvals](https://i0.wp.com/images.chemnet.com/service/drug_dict/098/11098_1.jpg)
Teva Pharmaceutical has been given a green light by the European Commission (EC) for Lonquex, a rival to Amgen's blockbuster Neulasta. | New Drug Approvals
Prescribing patterns from medical chart abstraction of patients administered lipegfilgrastim: a pilot study in Europe
![Lonquex - Lipegfilgrastim 10mg/ml - 1 Seringa Segurança Preenchida 0,6ml SC (2 A 8C) - Teva - ÁgilMed - Medicamentos Especiais e Nutrição Clínica Lonquex - Lipegfilgrastim 10mg/ml - 1 Seringa Segurança Preenchida 0,6ml SC (2 A 8C) - Teva - ÁgilMed - Medicamentos Especiais e Nutrição Clínica](https://cdn.awsli.com.br/600x450/476/476175/produto/33796109/adb4eb413d.jpg)
Lonquex - Lipegfilgrastim 10mg/ml - 1 Seringa Segurança Preenchida 0,6ml SC (2 A 8C) - Teva - ÁgilMed - Medicamentos Especiais e Nutrição Clínica
![G-CSF (Granulocyte Colony Stimulating Factors) Market Analysis, Size And Trends Global Forecast To 2022-2030 G-CSF (Granulocyte Colony Stimulating Factors) Market Analysis, Size And Trends Global Forecast To 2022-2030](https://www.thebusinessresearchcompany.com/infographimages/210104_G-CSF_(Granulocyte%20Colony%20Stimulating%20Factors).png)
G-CSF (Granulocyte Colony Stimulating Factors) Market Analysis, Size And Trends Global Forecast To 2022-2030
![Efficacy and safety of lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in breast cancer patients in Poland Efficacy and safety of lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in breast cancer patients in Poland](https://www.archivesofmedicalscience.com/f/pictures/140623_bf70d.jpg)
Efficacy and safety of lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in breast cancer patients in Poland
![Schematic structures of pegfilgrastim. Notes: (A) A recombinant form of... | Download Scientific Diagram Schematic structures of pegfilgrastim. Notes: (A) A recombinant form of... | Download Scientific Diagram](https://www.researchgate.net/profile/Roberto-Guariglia/publication/291823565/figure/fig1/AS:613883194654722@1523372567340/Schematic-structures-of-pegfilgrastim-Notes-A-A-recombinant-form-of-G-CSF-to-which-a.png)